✦ LIBER ✦

Low–molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus*

✍ Scribed by Dean J. Kereiakes; Gilles Montalescot; Elliott M. Antman; Marc Cohen; Harald Darius; James J. Ferguson; Cindy Grines; Karl R. Karsch; Neal S. Kleiman; David J. Moliterno; Phillippe-Gabriel Steg; Paul Teirstein; Frans Van de Werf; Lars Wallentin

Book ID: 117842906
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 152 KB
Volume: 144
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2002.124405

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-molecular-weight heparin use in acut

Low-molecular-weight heparin use in acute coronary syndromes and percutaneous coronary interventions: An update

✍ Jeffrey J. Link; John J. Warner; James A. de Lemos 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 255 KB

Primary percutaneous coronary interventi

Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen

✍ Sargis Khoobiar; Nicolai Mejevoi; Khalil Kaid; Catalin Boiangiu; Sampoornima Set 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 233 KB

Low molecular weight heparin versus unfr

Low molecular weight heparin versus unfractionated heparin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stents

✍ Yong-Jian Li; Seung Woon Rha; Kang-Yin Chen; Zhe Jin; Lin Wang; Sureshkumar Rama 📂 Article 📅 2012 🏛 Elsevier 🌐 Japanese ⚖ 349 KB

Catheter thrombosis during primary percu

Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment

✍ Christopher E. Buller; Gordon E. Pate; Paul W. Armstrong; Blair J. O’Neill; John 📂 Article 📅 2006 🏛 Pulsus Group Inc 🌐 English ⚖ 143 KB

Low-molecular-weight heparins vs. unfrac

Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis

✍ E. P. NAVARESE; G. DE LUCA; F. CASTRIOTA; M. KOZINSKI; P.A. GURBEL; C. M. GIBSON 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB

Effectiveness and Safety of Reduced-Dose

Effectiveness and Safety of Reduced-Dose Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndrome Followed by Antiplatelet Therapy Alone for Percutaneous Coronary Intervention

✍ Scott J. Denardo; Keith E. Davis; James E. Tcheng 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 102 KB